Showing results (3461-3470 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|January 1, 1997
Rationale for the use of calcium antagonists in the treatment of silent myocardial ischemiaP F CohnClinical Therapeutics|April 2, 1998
Oropharyngeal candidiasis: a review of its clinical spectrum and current therapiesJ B Epstein, B PolskyClinical Therapeutics|April 2, 1998
Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitisS Esposito, G De Ritis, G D'Errico, et al.Clinical Therapeutics|April 2, 1998
Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasiaD F Mobley, N Dias, M LevensteinClinical Therapeutics|August 6, 2016
Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General PracticeAbigail Tebboth, Sally Lee, Anna Scowcroft, et al.Clinical Therapeutics|August 6, 2016
Lack of a Pharmacokinetic Interaction Between Saxagliptin and Dapagliflozin in Healthy Subjects: A Randomized Crossover StudyBlisse Vakkalagadda, Susan Lubin, Laurie Reynolds, et al.Clinical Therapeutics|August 10, 2016
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan MonotherapyKwang-Il Kim, Mi-Seung Shin, Sang-Hyun Ihm, et al.Clinical Therapeutics|January 1, 1984
Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effectsH Tsutsui, H Araki, Y Nagata, et al.Clinical Therapeutics|January 1, 1983
Absorption and antiarrhythmic efficacy of sustained-release mexiletineD W Holt, D E Chadwick, R W CampbellPageof 680